ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dalbavancin Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-27J9592
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dalbavancin Market Insights Forecast to 2028
BUY CHAPTERS

Global Dalbavancin Market Insights, Forecast to 2030

Code: QYRE-Auto-27J9592
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Pfizer Inc
AbbVie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen Inc
Hayao

Dalbavancin Market

Dalbavancin is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA).
The global Dalbavancin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Dabavan star is a new antibiotic developed by Durata, named Dalvance, which was approved by FDA to be marketed in the United States on May 23, 2014. It is used to treat complex acute bacterial skin and skin structure infections in adults. The drug is a second-generation glycopeptide antibiotic given intravenously.
Report Covers:
This report presents an overview of global market for Dalbavancin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dalbavancin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dalbavancin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dalbavancin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dalbavancin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dalbavancin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Dalbavancin Market Report

Report Metric Details
Report Name Dalbavancin Market
Segment by Type
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbvie, Johnson, Sanofi, Merck, Novartis, Gilead, GSK, Amgen, Hayao
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Dalbavancin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dalbavancin sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dalbavancin Market report?

Ans: The main players in the Dalbavancin Market are Abbvie, Johnson, Sanofi, Merck, Novartis, Gilead, GSK, Amgen, Hayao

What are the Application segmentation covered in the Dalbavancin Market report?

Ans: The Applications covered in the Dalbavancin Market report are Skin Infection, Soft Tissue Infection, Others

What are the Type segmentation covered in the Dalbavancin Market report?

Ans: The Types covered in the Dalbavancin Market report are Intravenous Therapy, Oral Type

Recommended Reports

Antibiotic Markets

Infection Treatment

Skin Disease Therapy

1 Study Coverage
1.1 Dalbavancin Product Introduction
1.2 Market by Type
1.2.1 Global Dalbavancin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Intravenous Therapy
1.2.3 Oral Type
1.3 Market by Application
1.3.1 Global Dalbavancin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Skin Infection
1.3.3 Soft Tissue Infection
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dalbavancin Sales Estimates and Forecasts 2019-2030
2.2 Global Dalbavancin Revenue by Region
2.2.1 Global Dalbavancin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dalbavancin Revenue by Region (2019-2024)
2.2.3 Global Dalbavancin Revenue by Region (2025-2030)
2.2.4 Global Dalbavancin Revenue Market Share by Region (2019-2030)
2.3 Global Dalbavancin Sales Estimates and Forecasts 2019-2030
2.4 Global Dalbavancin Sales by Region
2.4.1 Global Dalbavancin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dalbavancin Sales by Region (2019-2024)
2.4.3 Global Dalbavancin Sales by Region (2025-2030)
2.4.4 Global Dalbavancin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dalbavancin Sales by Manufacturers
3.1.1 Global Dalbavancin Sales by Manufacturers (2019-2024)
3.1.2 Global Dalbavancin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dalbavancin in 2023
3.2 Global Dalbavancin Revenue by Manufacturers
3.2.1 Global Dalbavancin Revenue by Manufacturers (2019-2024)
3.2.2 Global Dalbavancin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dalbavancin Revenue in 2023
3.3 Global Key Players of Dalbavancin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dalbavancin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dalbavancin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dalbavancin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dalbavancin, Product Offered and Application
3.8 Global Key Manufacturers of Dalbavancin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dalbavancin Sales by Type
4.1.1 Global Dalbavancin Historical Sales by Type (2019-2024)
4.1.2 Global Dalbavancin Forecasted Sales by Type (2025-2030)
4.1.3 Global Dalbavancin Sales Market Share by Type (2019-2030)
4.2 Global Dalbavancin Revenue by Type
4.2.1 Global Dalbavancin Historical Revenue by Type (2019-2024)
4.2.2 Global Dalbavancin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dalbavancin Revenue Market Share by Type (2019-2030)
4.3 Global Dalbavancin Price by Type
4.3.1 Global Dalbavancin Price by Type (2019-2024)
4.3.2 Global Dalbavancin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dalbavancin Sales by Application
5.1.1 Global Dalbavancin Historical Sales by Application (2019-2024)
5.1.2 Global Dalbavancin Forecasted Sales by Application (2025-2030)
5.1.3 Global Dalbavancin Sales Market Share by Application (2019-2030)
5.2 Global Dalbavancin Revenue by Application
5.2.1 Global Dalbavancin Historical Revenue by Application (2019-2024)
5.2.2 Global Dalbavancin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dalbavancin Revenue Market Share by Application (2019-2030)
5.3 Global Dalbavancin Price by Application
5.3.1 Global Dalbavancin Price by Application (2019-2024)
5.3.2 Global Dalbavancin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dalbavancin Market Size by Type
6.1.1 US & Canada Dalbavancin Sales by Type (2019-2030)
6.1.2 US & Canada Dalbavancin Revenue by Type (2019-2030)
6.2 US & Canada Dalbavancin Market Size by Application
6.2.1 US & Canada Dalbavancin Sales by Application (2019-2030)
6.2.2 US & Canada Dalbavancin Revenue by Application (2019-2030)
6.3 US & Canada Dalbavancin Market Size by Country
6.3.1 US & Canada Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dalbavancin Sales by Country (2019-2030)
6.3.3 US & Canada Dalbavancin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dalbavancin Market Size by Type
7.1.1 Europe Dalbavancin Sales by Type (2019-2030)
7.1.2 Europe Dalbavancin Revenue by Type (2019-2030)
7.2 Europe Dalbavancin Market Size by Application
7.2.1 Europe Dalbavancin Sales by Application (2019-2030)
7.2.2 Europe Dalbavancin Revenue by Application (2019-2030)
7.3 Europe Dalbavancin Market Size by Country
7.3.1 Europe Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dalbavancin Sales by Country (2019-2030)
7.3.3 Europe Dalbavancin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dalbavancin Market Size
8.1.1 China Dalbavancin Sales (2019-2030)
8.1.2 China Dalbavancin Revenue (2019-2030)
8.2 China Dalbavancin Market Size by Application
8.2.1 China Dalbavancin Sales by Application (2019-2030)
8.2.2 China Dalbavancin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dalbavancin Market Size by Type
9.1.1 Asia Dalbavancin Sales by Type (2019-2030)
9.1.2 Asia Dalbavancin Revenue by Type (2019-2030)
9.2 Asia Dalbavancin Market Size by Application
9.2.1 Asia Dalbavancin Sales by Application (2019-2030)
9.2.2 Asia Dalbavancin Revenue by Application (2019-2030)
9.3 Asia Dalbavancin Sales by Region
9.3.1 Asia Dalbavancin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dalbavancin Revenue by Region (2019-2030)
9.3.3 Asia Dalbavancin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dalbavancin Market Size by Type
10.1.1 Middle East, Africa and Latin America Dalbavancin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dalbavancin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dalbavancin Market Size by Application
10.2.1 Middle East, Africa and Latin America Dalbavancin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dalbavancin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dalbavancin Sales by Country
10.3.1 Middle East, Africa and Latin America Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dalbavancin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dalbavancin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Roche Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Abbvie
11.3.1 Abbvie Company Information
11.3.2 Abbvie Overview
11.3.3 Abbvie Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Abbvie Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbvie Recent Developments
11.4 Johnson
11.4.1 Johnson Company Information
11.4.2 Johnson Overview
11.4.3 Johnson Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Johnson Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Novartis Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Gilead
11.8.1 Gilead Company Information
11.8.2 Gilead Overview
11.8.3 Gilead Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Gilead Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gilead Recent Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Overview
11.9.3 GSK Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GSK Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GSK Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Amgen Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 Hayao
11.11.1 Hayao Company Information
11.11.2 Hayao Overview
11.11.3 Hayao Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hayao Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hayao Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dalbavancin Industry Chain Analysis
12.2 Dalbavancin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dalbavancin Production Mode & Process
12.4 Dalbavancin Sales and Marketing
12.4.1 Dalbavancin Sales Channels
12.4.2 Dalbavancin Distributors
12.5 Dalbavancin Customers
13 Market Dynamics
13.1 Dalbavancin Industry Trends
13.2 Dalbavancin Market Drivers
13.3 Dalbavancin Market Challenges
13.4 Dalbavancin Market Restraints
14 Key Findings in The Global Dalbavancin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Roche
Pfizer Inc
AbbVie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen Inc
Hayao
List of Tables
    Table 1. Global Dalbavancin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Intravenous Therapy
    Table 3. Major Manufacturers of Oral Type
    Table 4. Global Dalbavancin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Dalbavancin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Dalbavancin Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Dalbavancin Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Dalbavancin Revenue Market Share by Region (2019-2024)
    Table 9. Global Dalbavancin Revenue Market Share by Region (2025-2030)
    Table 10. Global Dalbavancin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Dalbavancin Sales by Region (2019-2024) & (K Units)
    Table 12. Global Dalbavancin Sales by Region (2025-2030) & (K Units)
    Table 13. Global Dalbavancin Sales Market Share by Region (2019-2024)
    Table 14. Global Dalbavancin Sales Market Share by Region (2025-2030)
    Table 15. Global Dalbavancin Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Dalbavancin Sales Share by Manufacturers (2019-2024)
    Table 17. Global Dalbavancin Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Dalbavancin Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Dalbavancin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Dalbavancin Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Dalbavancin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Dalbavancin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dalbavancin as of 2023)
    Table 23. Global Key Manufacturers of Dalbavancin, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Dalbavancin, Product Offered and Application
    Table 25. Global Key Manufacturers of Dalbavancin, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 28. Global Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 29. Global Dalbavancin Sales Share by Type (2019-2024)
    Table 30. Global Dalbavancin Sales Share by Type (2025-2030)
    Table 31. Global Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Dalbavancin Revenue Share by Type (2019-2024)
    Table 34. Global Dalbavancin Revenue Share by Type (2025-2030)
    Table 35. Dalbavancin Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Dalbavancin Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 38. Global Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 39. Global Dalbavancin Sales Share by Application (2019-2024)
    Table 40. Global Dalbavancin Sales Share by Application (2025-2030)
    Table 41. Global Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Dalbavancin Revenue Share by Application (2019-2024)
    Table 44. Global Dalbavancin Revenue Share by Application (2025-2030)
    Table 45. Dalbavancin Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Dalbavancin Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Dalbavancin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Dalbavancin Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Dalbavancin Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Dalbavancin Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Dalbavancin Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Dalbavancin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Dalbavancin Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Dalbavancin Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Dalbavancin Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Dalbavancin Sales by Country (2025-2030) & (K Units)
    Table 73. China Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 74. China Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 75. China Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 78. China Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 79. China Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Dalbavancin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Dalbavancin Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Dalbavancin Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Dalbavancin Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Dalbavancin Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Dalbavancin Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Dalbavancin Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Dalbavancin Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Dalbavancin Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Dalbavancin Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Dalbavancin Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Dalbavancin Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Dalbavancin Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Dalbavancin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Dalbavancin Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Dalbavancin Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Dalbavancin Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Dalbavancin Sales by Country (2025-2030) & (K Units)
    Table 107. Roche Company Information
    Table 108. Roche Description and Major Businesses
    Table 109. Roche Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Roche Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Roche Recent Developments
    Table 112. Pfizer Company Information
    Table 113. Pfizer Description and Major Businesses
    Table 114. Pfizer Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Pfizer Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Pfizer Recent Developments
    Table 117. Abbvie Company Information
    Table 118. Abbvie Description and Major Businesses
    Table 119. Abbvie Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Abbvie Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Abbvie Recent Developments
    Table 122. Johnson Company Information
    Table 123. Johnson Description and Major Businesses
    Table 124. Johnson Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Johnson Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Johnson Recent Developments
    Table 127. Sanofi Company Information
    Table 128. Sanofi Description and Major Businesses
    Table 129. Sanofi Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Sanofi Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Sanofi Recent Developments
    Table 132. Merck Company Information
    Table 133. Merck Description and Major Businesses
    Table 134. Merck Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Merck Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Merck Recent Developments
    Table 137. Novartis Company Information
    Table 138. Novartis Description and Major Businesses
    Table 139. Novartis Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Novartis Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Novartis Recent Developments
    Table 142. Gilead Company Information
    Table 143. Gilead Description and Major Businesses
    Table 144. Gilead Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. Gilead Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Gilead Recent Developments
    Table 147. GSK Company Information
    Table 148. GSK Description and Major Businesses
    Table 149. GSK Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. GSK Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. GSK Recent Developments
    Table 152. Amgen Company Information
    Table 153. Amgen Description and Major Businesses
    Table 154. Amgen Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Amgen Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Amgen Recent Developments
    Table 157. Hayao Company Information
    Table 158. Hayao Description and Major Businesses
    Table 159. Hayao Dalbavancin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 160. Hayao Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hayao Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Dalbavancin Distributors List
    Table 165. Dalbavancin Customers List
    Table 166. Dalbavancin Market Trends
    Table 167. Dalbavancin Market Drivers
    Table 168. Dalbavancin Market Challenges
    Table 169. Dalbavancin Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dalbavancin Product Picture
    Figure 2. Global Dalbavancin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dalbavancin Market Share by Type in 2023 & 2030
    Figure 4. Intravenous Therapy Product Picture
    Figure 5. Oral Type Product Picture
    Figure 6. Global Dalbavancin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Dalbavancin Market Share by Application in 2023 & 2030
    Figure 8. Skin Infection
    Figure 9. Soft Tissue Infection
    Figure 10. Others
    Figure 11. Dalbavancin Report Years Considered
    Figure 12. Global Dalbavancin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Dalbavancin Revenue 2019-2030 (US$ Million)
    Figure 14. Global Dalbavancin Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Dalbavancin Revenue Market Share by Region (2019-2030)
    Figure 16. Global Dalbavancin Sales 2019-2030 ((K Units)
    Figure 17. Global Dalbavancin Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Dalbavancin Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Dalbavancin Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Dalbavancin Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Dalbavancin Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Dalbavancin Sales YoY (2019-2030) & (K Units)
    Figure 23. China Dalbavancin Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Dalbavancin Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Dalbavancin Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Dalbavancin Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Dalbavancin Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Dalbavancin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Dalbavancin in the World: Market Share by Dalbavancin Revenue in 2023
    Figure 30. Global Dalbavancin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 32. Global Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 33. Global Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 34. Global Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Dalbavancin Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Dalbavancin Sales Share by Country (2019-2030)
    Figure 41. U.S. Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 44. Europe Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 46. Europe Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Dalbavancin Revenue Share by Country (2019-2030)
    Figure 48. Europe Dalbavancin Sales Share by Country (2019-2030)
    Figure 49. Germany Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 50. France Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 54. China Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 55. China Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 56. China Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 57. China Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 59. Asia Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 61. Asia Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Dalbavancin Revenue Share by Region (2019-2030)
    Figure 63. Asia Dalbavancin Sales Share by Region (2019-2030)
    Figure 64. Japan Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 68. India Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Dalbavancin Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Dalbavancin Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Dalbavancin Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Dalbavancin Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Dalbavancin Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Dalbavancin Sales Share by Country (2019-2030)
    Figure 75. Brazil Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Dalbavancin Revenue (2019-2030) & (US$ Million)
    Figure 80. Dalbavancin Value Chain
    Figure 81. Dalbavancin Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Vancomycin Market Research Report 2024
Global Methicillin Resistant Staphylococcus Aureus MRSA Treatment Market Research Report 2024
Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oritavancin Reagent Market Research Report 2024
Oxacillin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Teicoplanin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oritavancin API Market Research Report 2024
MRSA Antibiotic Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 2 Oxazolidone Market Insights Forecast to 2030
Liposomal Amikacin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Staphylococcal Infection Treatment Market Insights Forecast to 2030
Global Vancomycin Hydrochloride Capsules Market Research Report 2024
Global Beta lactam and Beta lactamase Inhibitors Market Research Report 2025
MRSA Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VRE and MRSA Antibiotic Market
Global Aminoglycoside Drug Market Research Report 2025
Global Linezolid Drug Market Research Report 2024
Global Vancomycin Hydrochloride Market Research Report 2025
Methicillin Resistant Staphylococcus Aureus MRSA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aminoglycosides Antibiotics Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions